Diagnostic Medical Systems SA
F:DMS1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Diagnostic Medical Systems SA
F:DMS1
|
FR |
|
R
|
Ryman Healthcare Ltd
F:RH7
|
NZ |
|
L
|
LY Corp
SWB:YOJ
|
JP |
|
Vodacom Group Ltd
F:5VD0
|
ZA |
|
B
|
Barclays PLC
DUS:BCY
|
UK |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
Anoto Group AB
F:XTL1
|
SE |
|
Crane Co
F:T12
|
US |
|
Tharisa PLC
F:7YZ
|
CY |
|
F
|
Fastly Inc
F:2Y7
|
US |
|
O
|
OC Oerlikon Corporation AG Pfaeffikon
XMUN:OBH
|
CH |
|
H
|
Humm Group Ltd
F:F5L
|
AU |
|
Stadio Holdings Ltd
F:0JX
|
ZA |
|
Fujikura Ltd
F:FJK
|
JP |
|
W
|
Waters Corp
XMUN:WAZ
|
US |
|
Next Biometrics Group ASA
F:NT7
|
NO |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
|
4Front Ventures Corp
OTC:FFNTF
|
US |
Wall St Price Targets
DMS1 Price Targets Summary
Diagnostic Medical Systems SA
According to Wall Street analysts, the average 1-year price target for DMS1 is 1.984 EUR with a low forecast of 1.871 EUR and a high forecast of 2.139 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMS1's stock price target?
Price Target
1.984
EUR
According to Wall Street analysts, the average 1-year price target for DMS1 is 1.984 EUR with a low forecast of 1.871 EUR and a high forecast of 2.139 EUR.
What is the Revenue forecast for Diagnostic Medical Systems SA?
Projected CAGR
15%
Over the last 8 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Diagnostic Medical Systems SA?
Projected CAGR
76%
The compound annual growth rate for Operating Income over the next 3 years is 76%.
